EVERSANA to Present at the 41st Annual J.P. Morgan Healthcare Conference

On January 6, 2023 Jim Lang, Chief Executive Officer of EVERSANA, reported that pioneer of next-generation commercial services to the global life sciences industry, will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, California (Press release, EVERSANA, JAN 6, 2023, View Source [SID1234625962]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Lang, along with Chief Financial Officer Kelly Baker and Chief Digital Officer Scott Snyder, will be among EVERSANA leaders connecting with analysts and sharing market insights behind the company’s rapid evolution, from just over 1,000 employees in 2018 to more than 7,000 employees across 16 countries in 2022.

Since its launch in 2018, EVERSANA has built the industry’s first fully integrated commercialization solution, serving more than 650 partners ranging from established pharmaceutical companies to emerging start-ups. EVERSANA’s global commercial services are recognized for improving the launch and long-term in-market success for products across more than 50 therapeutic indications, including oncology, as well as advanced digital therapeutics.

"This conference is widely recognized as the global intersection of investment and innovation," said Lang. "We’re honored to get a chance to tell our story. But more so, we are humbled to share how our pharmaceutical clients are partnering with us as we transform an industry through digital innovation, award-winning client service, and an unwavering commitment to patients."

Lang will present on Monday, January 9, 2023, at 5:00 p.m. PST. Interested media or investors who wish to schedule a meeting with EVERSANA leadership can contact [email protected].